Childhood Leukemia, Lymphoma, and Histiocytosis

The Hematologic Malignancy Center at Dana-Farber/Boston Children's Cancer and Blood Disorders Center is one of the top pediatric leukemia and lymphoma treatment centers in the world. In addition to treating blood cancers — leukemias and lymphomas — our center treats the primary types of histiocytosis, a disease that shares many of the characteristics of cancer and is generally treated using similar therapies. We treat the following conditions:

Leukemia

• Acute lymphoblastic leukemia (ALL), including relapsed acute lymphoblastic leukemia
• Acute myeloid leukemia (AML)
• Chronic myeloid leukemia (CML)
• Juvenile myelomonocytic leukemia

Lymphoma

• Hodgkin lymphoma
• Non-Hodgkin lymphomas
  • Anaplastic large cell lymphoma
  • Burkitt lymphoma
  • Diffuse large B-cell lymphoma
  • Lymphoblastic lymphoma
  • Primary mediastinal B-cell lymphoma
  • Rare non-Hodgkin lymphomas

Histiocytosis

• Langerhans cell histiocytosis (LCH)
• Hemophagocytic lymphohistiocytosis (HLH)